Swedencare AB (publ) (FRA:7XY)

Market Cap	345.25M -40.1%
Revenue (ttm)	248.99M +6.1%
Net Income	5.13M -43.9%
EPS	0.03 -44.2%
Shares Out	n/a
PE Ratio	67.32
Forward PE	23.36
Dividend	0.02 (1.09%)
Ex-Dividend Date	Apr 25, 2025

Volume	n/a
Average Volume	n/a
Open	2.110
Previous Close	2.130
Day's Range	2.110 - 2.110
52-Week Range	2.075 - 4.265
Beta	n/a
RSI	41.85
Earnings Date	Apr 2, 2026

About Swedencare AB

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and so...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 613
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7XY

Financial Performance

In 2025, Swedencare AB's revenue was 2.69 billion, an increase of 6.09% compared to the previous year's 2.54 billion. Earnings were 55.50 million, a decrease of -43.88%.

Financial numbers in SEK